Xenon Pharmaceuticals Stock (NASDAQ:XENE), Quotes and News Summary

Q: What sector and industry does Xenon Pharmaceuticals (XENE) operate in?

Xenon Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Xenon Pharmaceuticals Stock (NASDAQ: XENE) stock price, news, charts, stock research, profile.

Open	$42.800
Close	-
Volume / Avg.	71.319K / 370.043K
Day Range	41.850 - 42.870
52 Wk Range	27.985 - 50.990
Market Cap	$3.204B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	3.68%
Days to Cover	8.55

Recent News

This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset Kv7-7000's Phase 3 trial this year, reducing late-stage risks.

Vandana Singh

Why Xenon Pharmaceuticals Stock (XENE) Is Seeing Blue Skies Today

Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares are trading higher by 7.8% to $36.38 Thursday afternoon. The company announced the pricing of its upsized $300 million public offering of 8,461,542 common shares at

Henry Khederian

Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Xenon Pharmaceuticals (XENE) stock?

You can purchase shares of Xenon Pharmaceuticals (NASDAQ: XENE) through any online brokerage.

View our list of the best stock brokerages.

Who are Xenon Pharmaceuticals's (XENE) competitors?

There are no as such competitors for Xenon Pharmaceuticals.

What is the target price for Xenon Pharmaceuticals (XENE) stock?

The latest price target for Xenon Pharmaceuticals (NASDAQ: XENE) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 62.00 expecting XENE to rise to within 12 months (a possible 45.92% upside). 20 analyst firms have reported ratings in the last year.

Current Stock Price for Xenon Pharmaceuticals (XENE)?

The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $42.49 last updated May 1, 2024 at 4:00 PM EDT.

Does Xenon Pharmaceuticals (XENE) pay a dividend?

There are no upcoming dividends for Xenon Pharmaceuticals.

When is Xenon Pharmaceuticals (NASDAQ:XENE) reporting earnings?

Xenon Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is Xenon Pharmaceuticals (XENE) going to split?

There is no upcoming split for Xenon Pharmaceuticals.

What sector and industry does Xenon Pharmaceuticals (XENE) operate in?

Xenon Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.